NuVasive, Inc. (NASDAQ:NUVA) Q2 2023 Earnings Call Transcript
Juliet Cunningham: Thank you. Good afternoon, everyone. With me today are Chris Barry, Chief Executive Officer; and Matt Harbaugh, Chief Financial Officer.
Nuvasive Inc (NUVA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 46,830,000 | $45,709,535 | 2.67% | ||
| 2. | 6,791,000 | $6,651,224 | -18% | 0.1% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $48.23 | 2,000 | Director | 2,000 | 2020-11-09 | Filing | |
| $50.30 | 6,000 | Officer, Director | 141,516 | 2018-03-06 | Filing | |
| $48.57 | 6,000 | Officer, Director | 135,516 | 2018-03-01 | Filing | |
| $61.52 | 2,000 | Officer, Director | 120,425 | 2017-08-29 | Filing | |
| $66.22 | 5,000 | Officer, Director | 118,245 | 2017-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $58.00 | 5,000 | Officer, Director | 50,218 | 2022-04-13 | Filing | |
| $55.00 | 5,000 | Officer, Director | 55,218 | 2022-03-28 | Filing | |
| $70.00 | 5,000 | Officer, Director | 9,926 | 2021-06-25 | Filing | |
| $68.00 | 5,000 | Officer, Director | 14,926 | 2021-06-21 | Filing | |
| $68.23 | 3,399 | Officer | 667 | 2021-05-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 28,894,000 | $26,637,761 | 0.77% | |
| 2. | 26,600,000 | $24,754,625 | 0.23% | |
| 3. | Aviva PlcBOND | 24,410,000 | $22,877,418 | 0.08% |
| 4. | 17,570,000 | $16,403,429 | 0.29% | |
| 5. | 16,500,000 | $15,221,251 | 0.04% |
News See All
NuVasive, Inc. (NASDAQ:NUVA) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the NuVasive First Quarter 2023 Earnings Conference Call. I would now like to introduce your host for today's call, Ms.
Here’s What Happened to NuVasive (NUVA) After Takeover Deal
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
NuVasive, Inc. (NASDAQ:NUVA) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the NuVasive Fourth Quarter and Full Year 2022 Earnings Conference Call. I would now like to introduce your host for today's call, Ms.
15 Largest Orthopedic Companies in the World
The orthopedic industry has staged a comeback in the last two years following a dismal 2020 due to the lockdowns and restrictions during the COVID-19 pandemic.
13 Best Medical Device Stocks To Buy Now
In this article, we will discuss the 13 Best Medical Device Stocks To Buy Now.
Hedge Funds Are Coming Back To NuVasive, Inc. (NUVA)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
Hedge Funds Are Souring On NuVasive, Inc. (NUVA)
In this article we will check out the progression of hedge fund sentiment towards NuVasive, Inc. (NASDAQ:NUVA) and determine whether it is a good investment right now.
Is NUVA Stock A Buy or Sell?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December...
Were These Hedge Funds Wrong About Betting On NuVasive, Inc. (NUVA)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Billionaire Hedge Funds
